What Are GLP-1 Drugs for Weight Loss?

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists are medications that activate a hormone pathway controlling appetite, food intake, and blood sugar regulation. Originally developed for type 2 diabetes, these drugs have shown significant weight loss results in clinical trials—with some patients losing 15-22% of body weight over 68 weeks. PlexusDx makes precision GLP-1 therapy accessible across all 50 states through licensed compounding pharmacies, starting at $149 per month for semaglutide injections.

How GLP-1 Medications Work for Weight Loss

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally produces after eating. When you activate GLP-1 receptors in the brain, they send signals that increase fullness, slow stomach emptying, and reduce cravings. This mechanism makes eating smaller portions feel satisfying, and many patients report less interest in food overall. The effect is not from stimulating your nervous system like older diet pills—it's a physiological signal that your body already recognizes.

Semaglutide and tirzepatide are the two main GLP-1 drugs prescribed for weight loss. Semaglutide activates only GLP-1 receptors, while tirzepatide also activates GIP receptors, offering a dual-pathway approach. Both require weekly injections or daily oral doses, and both are delivered through PlexusDx's licensed 503A compounding pharmacies to ensure pharmaceutical-grade quality. Your starting dose is low and adjusted based on tolerance and results—your price stays the same as your dose increases.

GLP-1 Weight Loss Results from Clinical Trials

The STEP trials, which studied semaglutide for chronic weight management, enrolled over 4,500 adults with overweight or obesity. Participants taking semaglutide 2.4 mg weekly lost an average of 10-15% of body weight over 68 weeks, compared to 2-3% in the placebo group. When combined with lifestyle changes like nutrition counseling and increased physical activity, results improved further. These outcomes represented a major shift in how the medical community approached pharmacologic weight loss—moving from marginal effects to clinically meaningful change.

Tirzepatide trials (SUMO program) showed even stronger results, with some patients losing 20-22% of body weight at the highest doses. Both medications reduced cardiovascular risk markers including blood pressure, cholesterol, and inflammatory markers. The consistency of these findings across thousands of patients demonstrates that GLP-1 activation addresses a core driver of weight gain: dysregulated appetite signaling. PlexusDx patients benefit from these same evidence-backed compounds, formulated by licensed pharmacies to meet strict quality standards.

Choosing Between Semaglutide, Tirzepatide, and Dual Therapy

Semaglutide injection at $149/month is often the starting point for GLP-1 therapy because it has the longest safety track record and a well-understood side-effect profile. Oral semaglutide ($249/month) offers convenience for needle-averse patients, though it requires an empty stomach and specific timing. Tirzepatide injection ($249/month) targets two pathways—GLP-1 and GIP—which may produce faster or more robust weight loss for some patients. PlexusDx pricing is flat per medication regardless of dose, so you never pay more as your dose climbs toward optimal results.

For patients seeking maximum metabolic impact, PlexusDx offers GLP-Squared Injection ($249/month), a compounded dual therapy combining semaglutide and tirzepatide. This approach activates both GLP-1 and GIP receptors simultaneously while keeping total injection volume manageable. The right choice depends on your metabolism, lifestyle, and how your body responds—which is why the Precision Peptide Genetic Test ($99) identifies your genetic predispositions across 14 peptide pathways and 49 specific compounds. This test guides your provider to therapies most likely to work for your biology.

Side Effects and Safety Considerations

Common side effects of GLP-1 drugs include nausea, vomiting, constipation, and reduced appetite for foods you previously enjoyed—the appetite reduction is therapeutic, while GI symptoms typically fade within weeks. Starting at a low dose and titrating gradually minimizes nausea in most patients. Rare but serious risks include pancreatitis and gallbladder issues; patients with a personal or family history of medullary thyroid cancer should not use these medications. PlexusDx requires a patient history and provider consultation before dispensing, ensuring screening for contraindications and baseline safety monitoring.

Dehydration is an often-overlooked safety concern with GLP-1 therapy because reduced eating can lower overall fluid intake. Patients are advised to drink water consistently and eat protein-rich foods to maintain muscle during weight loss. If you experience severe abdominal pain, vomiting, or signs of pancreatitis, seek emergency care immediately. PlexusDx provides patient education resources and works with licensed compounding pharmacies that follow strict quality protocols—all medications are formulated in 503A facilities, not mass-produced 503B plants, ensuring personalized oversight.

GLP-1 Therapy Cost and Access Through PlexusDx

PlexusDx eliminates barriers to GLP-1 therapy: no insurance required, no membership fees, and service in all 50 states. Semaglutide injection starts at $149/month, making it one of the most affordable entry points to GLP-1 weight loss. HSA and FSA accounts are accepted, offering additional savings for eligible patients. PlexusDx's commitment to flat pricing means your monthly cost never increases as your dose increases—your price stays exactly the same whether you're on a starting dose or fully optimized.

The Precision Peptide Genetic Test ($99) is available as an optional add-on after your first month of treatment. This test analyzes genetic variants in GLP1R, GIPR, FTO, MC4R, and other key loci to predict your response across 150+ personalized health insights. Rather than trial-and-error, this test helps PlexusDx providers select the therapy and dose strategy most aligned with your genetic profile. Combined with affordable monthly pricing and no membership commitment, this model brings precision weight loss within reach for people across income levels.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I lose weight on a GLP-1 drug like semaglutide?

Most patients notice reduced appetite within 1-2 weeks, but significant weight loss typically begins after 4-8 weeks as the dose is optimized. Clinical trials show steady weight loss over 12-16 weeks of consistent therapy. PlexusDx providers work with you to adjust dosing for best results while minimizing side effects.

Is compounded semaglutide as effective as brand-name Ozempic?

PlexusDx sources semaglutide from licensed 503A compounding pharmacies using pharmaceutical-grade active ingredients formulated to the same specifications as brand medications. Clinical studies confirm that semaglutide's mechanism and weight loss efficacy depend on the active compound itself, not the manufacturer. All PlexusDx therapies meet strict compounding standards and quality checks.

What does 'your dose may go up, your price won't' mean?

PlexusDx pricing is flat per medication—semaglutide injection is $149/month whether you're on a 0.5 mg or 2.4 mg weekly dose. As your provider increases your dose for optimal results, your monthly cost remains unchanged. This model removes the cost-escalation barrier that discourages dose optimization in other GLP-1 programs.

Are there serious side effects I should know about with GLP-1 drugs?

Nausea and constipation are common but typically fade within weeks. Rare serious risks include pancreatitis and thyroid issues in susceptible patients. PlexusDx requires a patient history review and provider consultation to screen for contraindications before dispensing any medication, ensuring your safety.

How does the Precision Peptide Genetic Test help with GLP-1 therapy?

The test analyzes genetic variants in GLP1R, GIPR, FTO, MC4R, and 10 other pathways across 49 peptides to predict your individual response to different GLP-1 therapies. This guides your PlexusDx provider toward semaglutide, tirzepatide, or dual therapy most likely to work for your unique biology, improving outcomes and reducing trial-and-error.

Related Reading

• Glp 1 Drugs For Weight Loss
• Glp 1 For Weight Loss 2
• Glp 1 Weight Loss Before And After
• Glp 1 Dosage For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.